KLSE: GENTING (3182)       GENTING BHD MAIN : Consumer
Last Price Today's Change   Day's Range   Trading Volume
4.66   +0.07 (1.53%)  4.59 - 4.70  5,014,700
Trade this stock for as low as 0.05% brokerage. Find out more.

Additional Listing

Hints :
[1] Click the View Entitlement icon table to view the Additional Listing detail page.

Click here to modify the Visible Columns.

Ann. Date Date Type Units Price Total NOSH View
09-Jan-2014 10-Jan-2014 Others 376,306 7.960 3,719,861,076 Additional Listing Detail
15-Jan-2014 16-Jan-2014 Others 18,700 7.960 3,719,879,776 Additional Listing Detail
21-Jan-2014 22-Jan-2014 Others 1,750 7.960 3,719,881,526 Additional Listing Detail
22-Jan-2014 23-Jan-2014 Others 1,005,926 7.960 3,720,887,452 Additional Listing Detail
28-Jan-2014 29-Jan-2014 Others 13,500 7.960 3,720,900,952 Additional Listing Detail
06-Feb-2014 07-Feb-2014 Others 8,060,000 7.960 3,728,960,952 Additional Listing Detail
10-Feb-2014 11-Feb-2014 Others 286,000 7.960 3,729,246,952 Additional Listing Detail
14-Feb-2014 17-Feb-2014 Others 8,205,675 7.960 3,737,452,627 Additional Listing Detail
18-Feb-2014 19-Feb-2014 Others 3,686,162 7.960 3,741,138,789 Additional Listing Detail
20-Feb-2014 21-Feb-2014 Others 462,500 7.960 3,741,601,289 Additional Listing Detail
25-Feb-2014 26-Feb-2014 Others 178,500 7.960 3,741,779,789 Additional Listing Detail
06-Mar-2014 07-Mar-2014 Others 76,250 7.960 3,741,856,039 Additional Listing Detail
12-Mar-2014 13-Mar-2014 Others 7,500 7.960 3,741,863,539 Additional Listing Detail
18-Mar-2014 19-Mar-2014 Others 250 7.960 3,741,863,789 Additional Listing Detail
20-Mar-2014 21-Mar-2014 Others 500 7.960 3,741,864,289 Additional Listing Detail
01-Apr-2014 02-Apr-2014 Others 250 7.960 3,741,864,539 Additional Listing Detail
07-Apr-2014 08-Apr-2014 Others 50 7.960 3,741,864,589 Additional Listing Detail
10-Apr-2014 11-Apr-2014 Others 751 7.960 3,741,865,340 Additional Listing Detail
02-May-2014 05-May-2014 Others 2,000 7.960 3,741,867,340 Additional Listing Detail
21-May-2014 22-May-2014 Others 250 7.960 3,741,867,590 Additional Listing Detail
26-May-2014 27-May-2014 Others 2,750 7.960 3,741,870,340 Additional Listing Detail
29-May-2014 30-May-2014 Others 2,000 7.960 3,741,872,340 Additional Listing Detail
02-Jun-2014 03-Jun-2014 Others 150 7.960 3,741,872,490 Additional Listing Detail
23-Jun-2014 24-Jun-2014 Others 325 7.960 3,741,872,815 Additional Listing Detail
30-Jul-2014 31-Jul-2014 Others 1,250 7.960 3,741,874,065 Additional Listing Detail
19-Sep-2014 22-Sep-2014 Others 15,000 7.960 3,741,889,065 Additional Listing Detail
23-Sep-2014 24-Sep-2014 Others 279,072 7.960 3,742,168,137 Additional Listing Detail
25-Sep-2014 26-Sep-2014 Others 880,069 7.960 3,743,048,206 Additional Listing Detail
03-Oct-2014 07-Oct-2014 Others 1,250 7.960 3,743,049,456 Additional Listing Detail
10-Oct-2014 13-Oct-2014 Others 250 7.960 3,743,049,706 Additional Listing Detail
29-Jan-2015 30-Jan-2015 Others 525 7.960 3,743,050,231 Additional Listing Detail
18-May-2015 19-May-2015 Exercise of Warrants 125 7.960 3,743,050,356 Additional Listing Detail
21-May-2015 22-May-2015 Exercise of Warrants 97,000 7.960 3,743,147,356 Additional Listing Detail
04-Jun-2015 05-Jun-2015 Exercise of Warrants 1,000 7.960 3,743,148,356 Additional Listing Detail
16-Jun-2015 17-Jun-2015 Exercise of Warrants 625 7.960 3,743,148,981 Additional Listing Detail
18-Jun-2015 19-Jun-2015 Exercise of Warrants 34,100 7.960 3,743,183,081 Additional Listing Detail
09-Jul-2015 10-Jul-2015 Exercise of Warrants 12,500 7.960 3,743,195,581 Additional Listing Detail
03-Aug-2015 04-Aug-2015 Exercise of Warrants 175 7.960 3,743,195,756 Additional Listing Detail
26-Apr-2016 27-Apr-2016 Exercise of Warrants 1,700 7.960 3,743,197,456 Additional Listing Detail
16-Jun-2016 17-Jun-2016 Exercise of Warrants 316 7.960 3,743,197,772 Additional Listing Detail
27-Jun-2016 28-Jun-2016 Exercise of Warrants 937 7.960 3,743,198,709 Additional Listing Detail
28-Jun-2016 29-Jun-2016 Exercise of Warrants 6,821,040 7.960 3,750,019,749 Additional Listing Detail
10-Oct-2016 11-Oct-2016 Exercise of Warrants 125 7.960 3,750,019,874 Additional Listing Detail
14-Dec-2016 15-Dec-2016 Exercise of Warrants 1,250 7.960 3,750,021,124 Additional Listing Detail
14-Mar-2017 15-Mar-2017 Exercise of Warrants 250 7.960 3,750,021,374 Additional Listing Detail
17-Mar-2017 20-Mar-2017 Exercise of Warrants 5,000 7.960 3,750,026,374 Additional Listing Detail
31-Mar-2017 03-Apr-2017 Exercise of Warrants 36,600 7.960 3,750,062,974 Additional Listing Detail
04-Apr-2017 05-Apr-2017 Exercise of Warrants 194,000 7.960 3,750,256,974 Additional Listing Detail
06-Apr-2017 07-Apr-2017 Exercise of Warrants 1,627,150 7.960 3,751,884,124 Additional Listing Detail
11-Apr-2017 12-Apr-2017 Exercise of Warrants 1,166,000 7.960 3,753,050,124 Additional Listing Detail
13-Apr-2017 14-Apr-2017 Exercise of Warrants 1,574,850 7.960 3,754,624,974 Additional Listing Detail
18-Apr-2017 19-Apr-2017 Exercise of Warrants 14,750 7.960 3,754,639,724 Additional Listing Detail
20-Apr-2017 21-Apr-2017 Exercise of Warrants 18,950 7.960 3,754,658,674 Additional Listing Detail
02-May-2017 03-May-2017 Exercise of Warrants 125 7.960 3,754,658,799 Additional Listing Detail
04-May-2017 05-May-2017 Exercise of Warrants 1,000 7.960 3,754,659,799 Additional Listing Detail
08-May-2017 09-May-2017 Exercise of Warrants 1,487,200 7.960 3,756,146,999 Additional Listing Detail
11-May-2017 12-May-2017 Exercise of Warrants 2,121,786 7.960 3,758,268,785 Additional Listing Detail
15-May-2017 16-May-2017 Exercise of Warrants 7,761,800 7.960 3,766,030,585 Additional Listing Detail
17-May-2017 18-May-2017 Exercise of Warrants 5,974,126 7.960 3,772,004,711 Additional Listing Detail
18-May-2017 19-May-2017 Exercise of Warrants 2,007,250 7.960 3,774,011,961 Additional Listing Detail
23-May-2017 24-May-2017 Exercise of Warrants 1,775,597 7.960 3,775,787,558 Additional Listing Detail
25-May-2017 26-May-2017 Exercise of Warrants 2,467,950 7.960 3,778,255,508 Additional Listing Detail
29-May-2017 30-May-2017 Exercise of Warrants 710,625 7.960 3,778,966,133 Additional Listing Detail
01-Jun-2017 02-Jun-2017 Exercise of Warrants 23,589,415 7.960 3,802,555,548 Additional Listing Detail
08-Jun-2017 09-Jun-2017 Exercise of Warrants 917,550 7.960 3,803,473,098 Additional Listing Detail
13-Jun-2017 14-Jun-2017 Exercise of Warrants 2,216,850 7.960 3,805,689,948 Additional Listing Detail
16-Jun-2017 19-Jun-2017 Exercise of Warrants 5,765,100 7.960 3,811,455,048 Additional Listing Detail
21-Jun-2017 22-Jun-2017 Exercise of Warrants 1,973,800 7.960 3,813,428,848 Additional Listing Detail
23-Jun-2017 28-Jun-2017 Exercise of Warrants 2,336,125 7.960 3,815,764,973 Additional Listing Detail
29-Jun-2017 30-Jun-2017 Exercise of Warrants 11,100 7.960 3,815,776,073 Additional Listing Detail
03-Jul-2017 04-Jul-2017 Exercise of Warrants 41,950 7.960 3,815,818,023 Additional Listing Detail
10-Jul-2017 11-Jul-2017 Exercise of Warrants 7,500 7.960 3,815,825,523 Additional Listing Detail
13-Jul-2017 14-Jul-2017 Exercise of Warrants 125 7.960 3,815,825,648 Additional Listing Detail
17-Jul-2017 18-Jul-2017 Exercise of Warrants 500 7.960 3,815,826,148 Additional Listing Detail
11-Aug-2017 14-Aug-2017 Exercise of Warrants 250 7.960 3,815,826,398 Additional Listing Detail
15-Aug-2017 16-Aug-2017 Exercise of Warrants 12,500 7.960 3,815,838,898 Additional Listing Detail
17-Aug-2017 18-Aug-2017 Exercise of Warrants 90,200 7.960 3,815,929,098 Additional Listing Detail
21-Aug-2017 22-Aug-2017 Exercise of Warrants 4,325,400 7.960 3,820,254,498 Additional Listing Detail
25-Aug-2017 28-Aug-2017 Exercise of Warrants 629,750 7.960 3,820,884,248 Additional Listing Detail
28-Aug-2017 29-Aug-2017 Exercise of Warrants 47,500 7.960 3,820,931,748 Additional Listing Detail
05-Sep-2017 06-Sep-2017 Exercise of Warrants 942,450 7.960 3,821,874,198 Additional Listing Detail
07-Sep-2017 08-Sep-2017 Exercise of Warrants 978,000 7.960 3,822,852,198 Additional Listing Detail
11-Sep-2017 12-Sep-2017 Exercise of Warrants 18,559,300 7.960 3,841,411,498 Additional Listing Detail
12-Sep-2017 13-Sep-2017 Exercise of Warrants 43,000 7.960 3,841,454,498 Additional Listing Detail
18-Sep-2017 19-Sep-2017 Exercise of Warrants 827,400 7.960 3,842,281,898 Additional Listing Detail
20-Sep-2017 21-Sep-2017 Exercise of Warrants 2,810,800 7.960 3,845,092,698 Additional Listing Detail
26-Sep-2017 27-Sep-2017 Exercise of Warrants 2,567,600 7.960 3,847,660,298 Additional Listing Detail
29-Sep-2017 02-Oct-2017 Exercise of Warrants 1,644,900 7.960 3,849,305,198 Additional Listing Detail
02-Oct-2017 03-Oct-2017 Exercise of Warrants 75,500 7.960 3,849,380,698 Additional Listing Detail
05-Oct-2017 06-Oct-2017 Exercise of Warrants 1,518,925 7.960 3,850,899,623 Additional Listing Detail
09-Oct-2017 10-Oct-2017 Exercise of Warrants 1,000 7.960 3,850,900,623 Additional Listing Detail
12-Oct-2017 13-Oct-2017 Exercise of Warrants 64,700 7.960 3,850,965,323 Additional Listing Detail
23-Oct-2017 24-Oct-2017 Exercise of Warrants 801,250 7.960 3,851,766,573 Additional Listing Detail
31-Oct-2017 01-Nov-2017 Exercise of Warrants 5,000 7.960 3,851,771,573 Additional Listing Detail
06-Nov-2017 07-Nov-2017 Exercise of Warrants 6,125 7.960 3,851,777,698 Additional Listing Detail
10-Nov-2017 13-Nov-2017 Exercise of Warrants 650 7.960 3,851,778,348 Additional Listing Detail
21-Nov-2017 22-Nov-2017 Exercise of Warrants 2,375 7.960 3,851,780,723 Additional Listing Detail
28-Nov-2017 29-Nov-2017 Exercise of Warrants 1,250 7.960 3,851,781,973 Additional Listing Detail
06-Dec-2017 07-Dec-2017 Exercise of Warrants 250 7.960 3,851,782,223 Additional Listing Detail
18-Jan-2018 19-Jan-2018 Exercise of Warrants 1,750 7.960 3,851,783,973 Additional Listing Detail
22-Jan-2018 23-Jan-2018 Exercise of Warrants 500 7.960 3,851,784,473 Additional Listing Detail
25-Jan-2018 26-Jan-2018 Exercise of Warrants 5,625 7.960 3,851,790,098 Additional Listing Detail
29-Jan-2018 30-Jan-2018 Exercise of Warrants 69,250 7.960 3,851,859,348 Additional Listing Detail
06-Feb-2018 07-Feb-2018 Exercise of Warrants 1,746,500 7.960 3,853,605,848 Additional Listing Detail
08-Feb-2018 09-Feb-2018 Exercise of Warrants 3,931,800 7.960 3,857,537,648 Additional Listing Detail
09-Feb-2018 12-Feb-2018 Exercise of Warrants 152,950 7.960 3,857,690,598 Additional Listing Detail
15-Feb-2018 19-Feb-2018 Exercise of Warrants 17,825 7.960 3,857,708,423 Additional Listing Detail
08-Mar-2018 09-Mar-2018 Exercise of Warrants 7,650 7.960 3,857,716,073 Additional Listing Detail
12-Mar-2018 13-Mar-2018 Exercise of Warrants 98,950 7.960 3,857,815,023 Additional Listing Detail
15-Mar-2018 16-Mar-2018 Exercise of Warrants 10,000 7.960 3,857,825,023 Additional Listing Detail
22-Mar-2018 23-Mar-2018 Exercise of Warrants 500 7.960 3,857,825,523 Additional Listing Detail
29-Mar-2018 30-Mar-2018 Exercise of Warrants 550 7.960 3,857,826,073 Additional Listing Detail
06-Apr-2018 09-Apr-2018 Exercise of Warrants 3,000 7.960 3,857,829,073 Additional Listing Detail
19-Apr-2018 20-Apr-2018 Exercise of Warrants 42,250 7.960 3,857,871,323 Additional Listing Detail
26-Apr-2018 27-Apr-2018 Exercise of Warrants 2,625 7.960 3,857,873,948 Additional Listing Detail
04-May-2018 07-May-2018 Exercise of Warrants 32,850 7.960 3,857,906,798 Additional Listing Detail
14-May-2018 15-May-2018 Exercise of Warrants 3,625 7.960 3,857,910,423 Additional Listing Detail
17-May-2018 18-May-2018 Exercise of Warrants 17,000 7.960 3,857,927,423 Additional Listing Detail
22-May-2018 23-May-2018 Exercise of Warrants 7,550 7.960 3,857,934,973 Additional Listing Detail
28-May-2018 30-May-2018 Exercise of Warrants 21,850 7.960 3,857,956,823 Additional Listing Detail
04-Jun-2018 05-Jun-2018 Exercise of Warrants 2,975 7.960 3,857,959,798 Additional Listing Detail
06-Jun-2018 07-Jun-2018 Exercise of Warrants 39,750 7.960 3,857,999,548 Additional Listing Detail
08-Jun-2018 11-Jun-2018 Exercise of Warrants 25,199 7.960 3,858,024,747 Additional Listing Detail
12-Jun-2018 13-Jun-2018 Exercise of Warrants 500 7.960 3,858,025,247 Additional Listing Detail
14-Jun-2018 18-Jun-2018 Exercise of Warrants 250 7.960 3,858,025,497 Additional Listing Detail
21-Jun-2018 22-Jun-2018 Exercise of Warrants 625 7.960 3,858,026,122 Additional Listing Detail
26-Jun-2018 27-Jun-2018 Exercise of Warrants 250 7.960 3,858,026,372 Additional Listing Detail
05-Jul-2018 06-Jul-2018 Exercise of Warrants 1,250 7.960 3,858,027,622 Additional Listing Detail
10-Jul-2018 11-Jul-2018 Exercise of Warrants 10,250 7.960 3,858,037,872 Additional Listing Detail
13-Jul-2018 16-Jul-2018 Exercise of Warrants 500 7.960 3,858,038,372 Additional Listing Detail
24-Jul-2018 25-Jul-2018 Exercise of Warrants 1,625 7.960 3,858,039,997 Additional Listing Detail
26-Jul-2018 27-Jul-2018 Exercise of Warrants 21,750 7.960 3,858,061,747 Additional Listing Detail
30-Jul-2018 31-Jul-2018 Exercise of Warrants 27,000 7.960 3,858,088,747 Additional Listing Detail
02-Aug-2018 03-Aug-2018 Exercise of Warrants 58,500 7.960 3,858,147,247 Additional Listing Detail
06-Aug-2018 07-Aug-2018 Exercise of Warrants 502,000 7.960 3,858,649,247 Additional Listing Detail
09-Aug-2018 10-Aug-2018 Exercise of Warrants 3,368,893 7.960 3,862,018,140 Additional Listing Detail
14-Aug-2018 15-Aug-2018 Exercise of Warrants 2,381,607 7.960 3,864,399,747 Additional Listing Detail
16-Aug-2018 17-Aug-2018 Exercise of Warrants 750 7.960 3,864,400,497 Additional Listing Detail
21-Aug-2018 23-Aug-2018 Exercise of Warrants 55,000 7.960 3,864,455,497 Additional Listing Detail
24-Aug-2018 27-Aug-2018 Exercise of Warrants 361,500 7.960 3,864,816,997 Additional Listing Detail
28-Aug-2018 29-Aug-2018 Exercise of Warrants 1,375 7.960 3,864,818,372 Additional Listing Detail
03-Sep-2018 04-Sep-2018 Exercise of Warrants 6,945,525 7.960 3,871,763,897 Additional Listing Detail
05-Sep-2018 06-Sep-2018 Exercise of Warrants 3,450,575 7.960 3,875,214,472 Additional Listing Detail
07-Sep-2018 12-Sep-2018 Exercise of Warrants 255,300 7.960 3,875,469,772 Additional Listing Detail
13-Sep-2018 14-Sep-2018 Exercise of Warrants 250 7.960 3,875,470,022 Additional Listing Detail
18-Sep-2018 19-Sep-2018 Exercise of Warrants 1,197,399 7.960 3,876,667,421 Additional Listing Detail
21-Sep-2018 24-Sep-2018 Exercise of Warrants 29,250 7.960 3,876,696,671 Additional Listing Detail
26-Sep-2018 27-Sep-2018 Exercise of Warrants 3,000 7.960 3,876,699,671 Additional Listing Detail
28-Sep-2018 01-Oct-2018 Exercise of Warrants 152,250 7.960 3,876,851,921 Additional Listing Detail
02-Oct-2018 03-Oct-2018 Exercise of Warrants 4,500 7.960 3,876,856,421 Additional Listing Detail
04-Oct-2018 05-Oct-2018 Exercise of Warrants 750 7.960 3,876,857,171 Additional Listing Detail
11-Oct-2018 12-Oct-2018 Exercise of Warrants 14,500 7.960 3,876,871,671 Additional Listing Detail
15-Oct-2018 16-Oct-2018 Exercise of Warrants 5,000 7.960 3,876,876,671 Additional Listing Detail
02-Nov-2018 05-Nov-2018 Exercise of Warrants 225 7.960 3,876,876,896 Additional Listing Detail
27-Nov-2018 28-Nov-2018 Exercise of Warrants 5,000 7.960 3,876,881,896 Additional Listing Detail
30-Nov-2018 03-Dec-2018 Exercise of Warrants 1,301 7.960 3,876,883,197 Additional Listing Detail
06-Dec-2018 07-Dec-2018 Exercise of Warrants 455 7.960 3,876,883,652 Additional Listing Detail
11-Dec-2018 12-Dec-2018 Exercise of Warrants 3,375 7.960 3,876,887,027 Additional Listing Detail
13-Dec-2018 14-Dec-2018 Exercise of Warrants 6,100 7.960 3,876,893,127 Additional Listing Detail
21-Dec-2018 24-Dec-2018 Exercise of Warrants 2,750 7.960 3,876,895,877 Additional Listing Detail
26-Dec-2018 27-Dec-2018 Exercise of Warrants 222 7.960 3,876,896,099 Additional Listing Detail
Analyze this stock with MQ Trader system

  34 people like this.
nicholas99 go genting big/ small.
30/03/2023 3:00 PM
Michael_chan2022 For 2023, it's only one way... GenB up..up up
30/03/2023 3:19 PM
AngTayKor Yes @ElGato, ATK small fish follow the whales. TaiKor super nice guy n very helpful person. Besides those funds he is managing, he n family owns abt 1% of Taurx. But he always overly bullish, everytime after talking to him you wont want to sell your taurx shares. Ha!

TaiKor will try to arrange the best deal for Taurx to benchmark the highest price. Those deals rejected by Taurx will then flow to secondary market. But i think this China fund can easily absorb both Taurx's new issues + plenty of shares on secondary market.
30/03/2023 3:59 PM
James_Bond Genting, hv faith, you will be rewarded greatly! Cheers!
30/03/2023 7:16 PM
ClaraChan94 Reinvest Genting when gets dividend next month
30/03/2023 7:36 PM
AngTayKor Posted by MoneyMakers > 3 hours ago | Report Abuse
No use TauRx - alrdy fail experiment/placebo
Even latest fundraising undersubscribed - nobody want

Aiyo got people really so stoopid ah? You smarter than billionaire investors?

Taurx rights issue was fully subscribed. GenB (LKT) even applied for excess rights else all the excess rights will be gobbled up by Chinese billionaire underwriter.
30/03/2023 9:04 PM
AngTayKor Posted by Mikecyc > 10 hours ago | Report Abuse
Haha Tin Kosong MonieM give lectures here ke …no more Shouting Rocket Limit Up ke as in Tsh .. don’t own deleted own posts loh …hahaha

@MM your enemy ah? Aiyo enemies chasing after you until coming into GenB forum. You must be spewing a lot of rubbish everywhere in i3. Tsk Tsk Tsk....
30/03/2023 9:13 PM
AngTayKor Posted by AngTayKor > 2022-11-07 15:54 | Report Abuse
TauRx Warrants Exercise
The latest results:-
1) 99.34% subscribed
2) amount raised = USD119.281 million.
Posted by MoneyMakers > 6 hours ago | Report Abuse
No use TauRx - alrdy fail experiment/placebo
Even latest fundraising undersubscribed - nobody want
Posted by MoneyMakers > 28 minutes ago | Report Abuse
Fact: TauRx reported only 99% warrant exercised (undersubscribed)
AngTK pls tell LKT or whichever chinese billionaire - still got 1% shares havent ‘gobble up’ kikiki

Aiyo really got people so dumb? Those attached piggyback warrants are non-transferable hence cannot be gobbled up by the underwriter. Its 99.34% VS 0.66%. Got 99.34% of warrant holders want. How can you say nobody want? Those 0.66% that failed to pay up on due date, its even better for other existing shareholders because less dilution at cheap price. ATK and many others also salivating want to gobble up those 0.66% warrant shares @USD45 each but legally unable to execute it. We are now talking abt issuing new shares at USD300/share. Those 0.66% that didnt pay up on due date too bad for them missed the golden huat opportunity to profit a few folds within a few months.

31/03/2023 12:19 AM
AngTayKor https://bm.cnfic.com.cn/sharing/share/articleDetail/165072276/1

@Michael your Chinese very good this article for you from the main news agency in China XinHua. Taurx got chance to get C.A in China also.
31/03/2023 12:43 AM
ElGato @ATK Very hopeful for CA in China especially with Xinhua News pushing for us.
31/03/2023 1:22 AM
AngTayKor Yes. All the best to Taurx and GenB shareholders. We will clear all the hurdles! MCI patient group average score 20% reversal (improvement) from initial baseline on a phase 3 trial is God's gift to mankind to defeat this devastating AD.
31/03/2023 1:56 AM
Michael_chan2022 Great to see more TauRx's news. Anxiously waiting for the re-rating of Genting TP. @ATK, thanks for sharing good news...
Let's all huat together. Cheers!
31/03/2023 8:59 AM
Mikecyc Haha no worries, a few years back , one of Genting Marketing Manager said the Income during the CNY 15 Days can cover 1 Year expenditures, foreseen Shl be improving …
31/03/2023 9:14 AM
James_Bond Go go go Genting… loving you! Cheers!
31/03/2023 9:21 AM
James_Bond Those who cut loss from Genting, please seek compensation from AngTayKor, Bob etc… hahaha…. I m right again! Cheers!
31/03/2023 10:47 AM
AngTayKor Posted by James_Bond > 4 minutes ago | Report Abuse
Those who cut loss from Genting, please seek compensation from AngTayKor, Bob etc… hahaha…. I m right again! Cheers!

Loser Justborn dont anyhow put words into ATK's mouth. ATK did not say nasty things abt GenB or tell people here to cutloss. Go n check back the records posted here. Justborn you have no credibility here n serious character problem. Justborn is a shameless Liar, Fraud, Loser.
31/03/2023 10:58 AM
MoneyMakers Aiyoyo AngTK obviously ‘nobody want’ = joke..main point is undersubscribe

This what happens when no life/friends - cannot understand joke

P/s: warrant usd45 ‘undersubscribe’ alrdy proof TauRx not worth usd300/share
31/03/2023 11:18 AM
MoneyMakers TauRx alrdy fail experiment/placebo - yet still try get approval

Approval fail = more fundraising (if can find @ alrdy multiple experiment fail) or abandon proj

Want invest GenT better dont look TauRx - focus postpandemic travel better
31/03/2023 11:24 AM
James_Bond Clearly see AngTayKor is not gentleman! Haha…
31/03/2023 11:28 AM
Peaches L If everyone here is truly a genuine Gent shareholder, u shud b happy for one another whether it’s TauRx or any other relevant news/information. Why behaving like dog bite dog bone kinda low and childish mentality? Promoting TauRx here benefits Gent shareholders as well. Tis platform shud b a harmonious place for all interested parties to share relevant and useful information for benefit of Gent shareholders primarily. Haiya… lose money quarrel, make money oso quarrel. Family with no peace and harmony disrupts good chi and feng sui energy.
31/03/2023 11:33 AM
James_Bond Marvelous Genting! Loving you!
31/03/2023 11:33 AM
novel23 thx @ATK sharing TauRX update. hope for approval soon.
31/03/2023 11:39 AM
casanwk Prior high - 463 - been broken.
Is time to ride 3 wave ( minicycle)...
31/03/2023 11:41 AM
Peaches L Yeah, TQVM @ATK for yr kindness to share TauRx’s latest developments w us. I appreciate you.
31/03/2023 11:42 AM
MoneyMakers Not good overhype TauRx leh

Better give accurate TauRx info (even if bad news)
31/03/2023 11:47 AM
Michael_chan2022 Son needs support, it's falling behind.. :)
31/03/2023 12:27 PM
Michael_chan2022 Very soon, 4 series will be history
31/03/2023 12:40 PM
AngTayKor Posted by James_Bond > 1 hour ago | Report Abuse
Clearly see AngTayKor is not gentleman! Haha…

Aiya obviously Justborn not happy with ATK hence keep cursing and falsely accusing ATK for all sorts of bad things. ATK was the first here to point out his 90m rupiah Casino Royale Fund is a fraud to fool the naive. From 5.00 kept on buying and supporting but price crashed below 4.50. 2 weeks ago after Justborn declared he had enough GenB shares and will will stop buying, price started to rally. Real 90m fund or fraud? You decide for yourself la.
31/03/2023 12:52 PM
AngTayKor Posted by MoneyMakers > 1 hour ago | Report Abuse
Not good overhype TauRx leh
Better give accurate TauRx info (even if bad news)

The bad news is, some funds only offered a low ball offer price to buy Taurx shares, which makes ATK's Taurx shares worth only USD30m.

The good news is, if big China Fund comes in and buy Taurx shares, ATK's Taurx shares will be worth USD58.5M (5% sold liow).

I dont have over rm90m cash la. There is only one liar, fraud and loser here that declared he has over rm90m cash. Hahaha.
31/03/2023 1:10 PM
DestinyL ATK, the China 3rd phase trial only recently started? Estimated trial period until?
31/03/2023 1:31 PM
1invest1 Thanks @Mikecyc for sharing info.
Haha Tin Kosong MonieM give lectures here ke …no more Shouting Rocket Limit Up ke as in Tsh .. don’t own deleted own posts loh …hahaha

Haha no worries, a few years back , one of Genting Marketing Manager said the Income during the CNY 15 Days can cover 1 Year expenditures, foreseen Shl be improving …
31/03/2023 1:58 PM
1invest1 Tks @Peaches L.
for your post for ALL in GB forum.

If everyone here is truly a genuine Gent shareholder, u shud b happy for one another whether it’s TauRx or any other relevant news/information. Why behaving like dog bite dog bone kinda low and childish mentality? Promoting TauRx here benefits Gent shareholders as well. Tis platform shud b a harmonious place for all interested parties to share relevant and useful information for benefit of Gent shareholders primarily. Haiya… lose money quarrel, make money oso quarrel. Family with no peace and harmony disrupts good chi and feng sui energy.
31/03/2023 2:02 PM
1invest1 @AngTayKor, your posts are valued by

@Peaches L,
@1invest1 and others.
31/03/2023 2:05 PM
AngTayKor Posted by AngTayKor > 1 month ago | Report Abuse

Firstly, we need to understand with Lucidity's placebo fiasco, full approval is not possible. What we are looking for is Conditional Approval (CA), meaning the regulators agree to let us commercialise HMTM pending results of a new retrial. Usually CA duration is abt 8 yrs (Aduhelm has it for 9 years). The trial design has to be approved by both EMA and FDA otherwise we will be doing 2 trials to satisfy each of them. These days regulators are getting strict with this CA loopholes because some drug companies didnt even do their retrial, some dragged their feet slowly for the trial to max out the CA duration while milking $ selling their drugs, some trials even failed but still selling refuse to pull off from the shelves. Regulators were weak in enforcing such CA approvals but they are getting their acts together now. FDA allows immediate commercialisation upon CA hence subject to a lot of system abuse by pharmas but they are trying to close many loopholes now. I think EMA is currently handling such system abuse better. They will only give the CA licence to commercialise the drug when the agreed retrial has reached full enrollment (all the patients has done their first-time-first-visit at the trial centres). I can talk all day here so better give short answer.

Taurx will submit document to FDA and EMA in March. Thereafter at least 6 months for approval, I suspect more likely 12 months or longer to know the outcome. Taurx have already submitted or submitting soon for some smaller countries for CA. Smaller countries that give fast track probably can get CA faster. Sandy Kingdom, UK, etc. Some some countries' CA may come soon, some later this year.

On the China side, Taurx has cancelled study TRx-237-801 (suppose to be a parallel trial with Lucidity) with the National Medical Products Administration (NMPA). Post Lucidity result, Taurx will be discussing with them on China CA and non-placebo new trial design as the drug can work but the trial did not work under Lucidity's trial design.

@DestinyL, not so fast yet. Still discussing with China NMPA on HMTM's C.A. and new non-placebo trial design in China. Meanwhile Biogen/Eisai has obtained fast track review for approval in China. But I think their approval wont be smooth eventually as the Chinese regulators are fully aware of Lecanemab's super low drug efficacy (27% slowdown in decline compared to placebo's decline) that comes with high risk of brain swelling/bleeding including numerous death cases.

31/03/2023 2:12 PM
wow...! GenS share price keeps moving Up! 天空才是它的极限...
31/03/2023 3:02 PM
GenB go..go go
31/03/2023 3:07 PM
MoneyMakers Eisai didnt fail experiment - TauRx fail experiment/placebo

Aduhelm effectiveness questionable (like TauRx) but approved by FDA - Aduhelm 2022 sales only usd5Mil

** Approval doesnt mean boombastic sales - Dr wont recommend if questionable treatment or got other/better alternative
31/03/2023 3:33 PM
MoneyMakers Aduhelm (FDA approved) only got usd5Mil sales - US known expensive medical cost

TauRx in China will earn much less - cheap healthcare
31/03/2023 3:52 PM
James_Bond Am earning more with GenS… +25% now… haha…
31/03/2023 4:20 PM
Michael_chan2022 Sembcorp u96 more solid..
31/03/2023 4:36 PM
MoneyMakers Ding3 4.66 (+9sen div) highest monthly closing!!

Rebounding nicely from banking panic (panic sell GenT 4 no reason)

Slow steady back to rm5
31/03/2023 5:10 PM
ClaraChan94 Momentum seems like to have recovered for Genting
31/03/2023 6:01 PM
Michael_chan2022 https://www.sinchew.com.my/?p=4580476

Maybe Anwar bring good news for GenB.. let's see
31/03/2023 7:52 PM
RWG anwar will allow open 10 more casino in msia
31/03/2023 8:01 PM
newbie2019 Good one Peaches L….. what I felt too…. Happy weekend guys….
31/03/2023 8:47 PM
RWG https://www.sinchew.com.my/20230331/%e5%80%aa%e5%8f%af%e6%95%8f%ef%bc%9a%e6%8e%a5%e5%8f%97%e5%ae%89%e5%8d%8e%e9%82%80%e8%af%b7-%e4%b9%a0%e8%bf%91%e5%b9%b3%e5%b0%86%e5%9b%9e%e8%ae%bf%e9%a9%ac/
01/04/2023 10:20 AM
Michael_chan2022 https://news.cgtn.com/news/2023-03-31/Xi-Jinping-meets-Malaysian-prime-minister-1iCOLNKBqdq/index.html

Xi's meeting with Anwar opens new chapter in China-Malaysia relations

China funds pouring in.. Hou seh liao!
01/04/2023 11:36 AM
Michael_chan2022 https://www.channelnewsasia.com/commentary/malaysia-singapore-relations-anwar-unity-government-3387506?cid=internal_sharetool_androidphone_01042023_cna

Anwar's unity government may write a new chapter for Malaysia-Singapore relations

Temasek's fund lai liao..

2023 could be a good year for KLCI. Huat AAAAA!
01/04/2023 11:41 AM
Serious Beijing pledges RM170 bil investments in Malaysia: Anwar
This a result of 19 MoUs inked, round-table with Chinese business leaders, says PM
01/04/2023 4:32 PM

wow! Good news keep coming.. 你播种了吗? Cheers!
02/04/2023 8:49 AM

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends

374  338  561  1000 

Top 10 Active Counters
 MMAG 0.020.00 
 MYEG 0.765+0.035 
 VINVEST 0.20-0.03 
 BSLCORP-WB 0.0150.00 
 HSI-HKX 0.09-0.02 
 CFM 0.215-0.01 
 FITTERS 0.080.00 
 HONGSENG 0.115+0.005 
 SAPNRG 0.0350.00 
 PERMAJU 0.065+0.005